MetaCap

NeoGenomics Earnings

NASDAQ: NEOHealth CarePrecision InstrumentsUSD

16.35+0.33 (+2.06%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Next earnings date

Tue, Oct 27, 2026

Fiscal period

Sep/2026

EPS estimate

$-0.01

NeoGenomics earnings summary

NeoGenomics is scheduled to report Sep/2026 earnings on Oct 27, 2026, with analysts expecting EPS of $-0.01. In its most recent report on Jul 28, 2026 (Q2 2026), NEO posted EPS of $0.02. Revenue for the quarter was $201.7 million.

Across the last 16 reports, NEO shares moved an average of 7.4% (in either direction) in the first trading session after results, rising 7 times and falling 9 times.

Summary generated from market data by MetaCap's automated system. Methodology

NEO earnings history

NeoGenomics reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Jul 28, 2026—$0.02—+8.4%
Apr 28, 2026—$-0.13—-5.1%
Feb 17, 2026—$-0.08—-0.6%
Oct 28, 2025—$-0.21—+3.2%
Jul 29, 2025—$-0.35—+12.4%
Apr 29, 2025—$-0.20—+4.5%
Feb 18, 2025—$-0.12—-10.0%
Nov 5, 2024—$-0.14—-4.6%
Jul 30, 2024—$-0.15—-3.6%
Apr 30, 2024—$-0.21—+3.1%
Feb 20, 2024—$-0.11—-4.9%
Nov 6, 2023—$-0.15—+23.2%
Aug 8, 2023—$-0.19—-3.6%
May 9, 2023—$-0.25—-7.5%
Feb 24, 2023—$-0.18—+14.0%
Nov 8, 2022—$-0.30—-9.6%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related